Sanofi Reports Positive Results for Next-Generation Respiratory Vaccine
French pharmaceutical company Sanofi has announced successful late-stage clinical trial results for a messenger RNA vaccine targeting multiple seasonal respiratory viruses, with European approval expected later this year.